Primary Recipient

SAINT LOUIS UNIVERSITY

Amount

$842,672.00

Award Date

9/25/2009

Administering Agency

Health and Human Services, Department of / National Institutes of Health

CDFA Number

93.701

CDFA Program Title

Trans-NIH Recovery Act Research Support

Description

There are no effective treatments for hepatic fibrosis. There+???s an urgent need to develop therapeutic agents that delay/reverse hepatic fibrosis. We believe that PEG-TGF-B peptantagonist should be an ideal candidate for treating human liver fibrosis.

Recipients Connected to Award

Recipient	Role	Amount
SAINT LOUIS UNIVERSITY	Primary recipient	$616,072.00
AUXAGEN INC.	Sub-recipient	$226,600.00